EU Supplementary Protection Certificate Mechanism Needs To Go, Say Campaigners

Brain
SPCs prolong monopolies of originator pharmaceutical companies, say campaigners • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet